{"result": "(\"entity\"<|>HIPERCOLESTEROLEMIA FAMILIAR<|>EVENT<|>Hipercolesterolemia familiar is a genetic disorder characterized by high levels of LDL cholesterol, occurring in approximately one in every million individuals in its homozygous form, leading to cholesterol levels exceeding 500 mg/dl.)\n##\n(\"entity\"<|>DM2<|>EVENT<|>Diabetes Mellitus Type 2 (DM2) is a condition where insulin resistance and obesity lead to mild to moderate hypertriglyceridemia and low HDL cholesterol levels, often associated with excess VLDL production.)\n##\n(\"entity\"<|>Hiperlipidemia Familiar Combinada<|>EVENT<|>Hiperlipidemia familiar combinada is a mixed or combined hyperlipidemia inherited in an autosomal dominant manner, which can present isolated hypertriglyceridemia or elevated cholesterol levels, with varying phenotypes over time.)\n##\n(\"entity\"<|>VLDL<|>ORGANIZATION<|>Very Low-Density Lipoprotein (VLDL) is a type of lipoprotein that carries triglycerides in the blood and is often elevated in conditions like DM2.)\n##\n(\"entity\"<|>LDL<|>ORGANIZATION<|>Low-Density Lipoprotein (LDL) is a type of cholesterol that can become small and dense, making it more atherogenic and contributing to cardiovascular risk.)\n##\n(\"entity\"<|>HDL<|>ORGANIZATION<|>High-Density Lipoprotein (HDL) is known as \"good\" cholesterol, which helps remove other forms of cholesterol from the bloodstream.)\n##\n(\"relationship\"<|>HIPERCOLESTEROLEMIA FAMILIAR<|>LDL<|>Hipercolesterolemia familiar is characterized by elevated levels of LDL cholesterol, which is a key factor in the disorder<|>8)\n##\n(\"relationship\"<|>DM2<|>VLDL<|>In DM2, there is often an excess production of VLDL, leading to elevated triglyceride levels<|>7)\n##\n(\"relationship\"<|>DM2<|>LDL<|>In DM2, LDL particles are often small and dense, which increases their atherogenic potential<|>6)\n##\n(\"relationship\"<|>Hiperlipidemia Familiar Combinada<|>VLDL<|>Hiperlipidemia familiar combinada can present with elevated levels of VLDL, contributing to the mixed hyperlipidemia<|>5)\n##\n(\"relationship\"<|>Hiperlipidemia Familiar Combinada<|>LDL<|>In Hiperlipidemia familiar combinada, LDL levels can also be elevated, contributing to cardiovascular risk<|>5)\n##\n(\"relationship\"<|>DM2<|>HDL<|>In DM2, HDL levels are often low, which is a risk factor for cardiovascular disease<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: normal a la insulina con los resistentes a esta, se observa que estos últimos\n                   intra- y extracelulares de colesterol en los tendones. La forma homocigota de hiperco-            tienen más partículas pequeñas y densas de LDL, VLDL e IDL, lo que refleja la elevación de\n                   lesterolemia familiar tiene una frecuencia de un individuo por millón y se acompaña de            la apo B en este grupo de pacientes. Las elevaciones plasmáticas de LDL no son una carac-\n                   niveles de colesterol plasmático superiores a 500 mg/dl.                                          terística típica del perfil lipídico del síndrome metabólico, si bien hay grupos de pacientes\n\n\n\n450                                                                                                                                                                                                                                          451\n---\n                                                                                                                                                                                                           OBESIDAD,               LÍPIDOS                       8\n                                                                                                                                                                              Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n         que sí las tienen, como consecuencia de la expresión de una gran cantidad de partículas                                         producción. Los elevados niveles de triglicéridos plasmáticos en ayunas (200-750 mg/dl)\n         pequeñas y densas de LDL. De hecho, esta aparente normalidad o poca elevación de las                                            suelen ser triglicéridos en VLDL. En las hipertrigliceridemias no aparecen xantomas si los\n         LDL hace subestimar el riesgo cardiovascular. Las LDL son un conjunto heterogéneo de                                            niveles de triglicéridos están por debajo de 1.000 mg/dl.\n         partículas lipoproteínicas que varían en tamaño, densidad, composición y capacidad atero-                                       Hipercolesterolemia familiar. Es un trastorno genético codominante que en forma heteroci-\n         génica. Todas comparten su carga de colesterol, pero cuando pierden su carga en triglicé-                                       gota se da aproximadamente en uno de cada 500 individuos. Se debe fundamentalmente a\n         ridos aumentan su densidad y reducen su tamaño, convirtiéndose en partículas pequeñas                                           mutaciones en el receptor de LDL y hasta la fecha se han descrito más de 200 mutaciones en\n         y densas de LDL (entre 12 y 18 nm). Esta forma de LDL es altamente aterogénica y, aunque                                        el receptor. Los niveles de colesterol LDL están elevados al nacer y permanecen así durante\n         la razón de que sean tan lesivas no está clara, solo ya desde el punto de vista mecánico su                                     toda la vida. En adultos no tratados, los niveles oscilan entre 275 y 500 mg/dl, mientras que\n         menor tamaño hace que atraviesen la pared endotelial con facilidad. Además, se sabe que                                         los niveles de triglicéridos y HDL permanecen normales e incluso bajos en estos últimos. Se\n         su pequeño tamaño hace que tengan mayor afinidad por los proteoglicanos de la íntima                                            observan xantomas tendinosos que son depósitos intra- y extracelulares de colesterol en los\n         de la pared arterial y que sean más susceptibles a la oxidación y, como consecuencia de                                         tendones. La forma homocigota de hipercolesterolemia familiar tiene una frecuencia de un in-\n         ello, a ser fagocitadas por los macrófagos, lo que conduce a la aparición o progresión de la                                    dividuo por millón y se acompaña de niveles de colesterol plasmático superiores a 500 mg/dl.\n         enfermedad ateromatosa.\n         En la DM2, la resistencia a la insulina y la obesidad se combinan para causar una hipertri-                                     Hiperlipidemia familiar combinada. Es una hiperlipidemia mixta o combinada. Se hereda\n         gliceridemia leve o moderada y bajos niveles de colesterol HDL. En general, este patrón de                                      de forma autosómica dominante y puede aparecer hipertrigliceridemia aislada o niveles\n         dislipidemia se debe a un exceso de producción de VLDL. El colesterol LDL suele ser normal                                      aislados elevados de colesterol o ambos; además, el fenotipo puede variar a lo largo del\n         en la DM2,      aunque las      partículas LDL       son pequeñas        y densas y está        descrito    que estas           tiempo. Se desconoce el trastorno de base, pero se ha descrito que en algunas familias pue-\n         lipoproteínas son más aterogénicas.                                                                                             den contribuir polimorfismos de la lipoproteína lipasa y del grupo de genes formado por las\n                                                                                                                                         apolipoproteínas A-I, C-III y A-IV. En muchos individuos se presenta resistencia a la insulina\n         Referencias:                                                                                                                    debido probablemente al flujo de ácidos grasos libres. Los pacientes con hiperlipemia fami-\n         • Cardona F, Alcaide J, Fernández García JC. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española         liar combinada tienen una captación reducida de los á\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}